BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38480095)

  • 1. Multiple peimary cancers in patient with malignant pleural mesothelioma and ovarian serous carcinoma: A case report.
    Tian D; Wang H; Zhu B; Liu H
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38480095
    [No Abstract]   [Full Text] [Related]  

  • 2. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
    Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
    Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.
    Vettukattil R; Hetland TE; Flørenes VA; Kærn J; Davidson B; Bathen TF
    Hum Pathol; 2013 Sep; 44(9):1859-66. PubMed ID: 23656974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.
    Brenne K; Nymoen DA; Hetland TE; Trope' CG; Davidson B
    Hum Pathol; 2012 Apr; 43(4):496-505. PubMed ID: 21855111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble AXL is ubiquitously present in malignant serous effusions.
    Flem Karlsen K; McFadden E; Flørenes VA; Davidson B
    Gynecol Oncol; 2019 Feb; 152(2):408-415. PubMed ID: 30448261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
    Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
    [No Abstract]   [Full Text] [Related]  

  • 7. The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
    Davidson B
    Cytopathology; 2011 Feb; 22(1):5-21. PubMed ID: 21114695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
    Yuan Y; Nymoen DA; Stavnes HT; Rosnes AK; Bjørang O; Wu C; Nesland JM; Davidson B
    Am J Surg Pathol; 2009 Nov; 33(11):1673-82. PubMed ID: 19738457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.
    Brusegard K; Stavnes HT; Nymoen DA; Flatmark K; Trope CG; Davidson B
    Virchows Arch; 2012 Feb; 460(2):193-202. PubMed ID: 22249560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
    Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report.
    Rhazari M; Moueqqit O; Gartini S; El Morabit S; Diani S; Aharmim M; Thouil A; Kouismi H; El Bourkadi JE
    Cureus; 2022 Apr; 14(4):e24478. PubMed ID: 35637829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
    Kishimoto T
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic role of BAP1 in serous effusions.
    Davidson B; Tötsch M; Wohlschlaeger J; Hager T; Pinamonti M
    Hum Pathol; 2018 Sep; 79():122-126. PubMed ID: 29802871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
    Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
    Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural neoplasm with both differentiation of epithelioid mesothelioma and squamous-cell carcinoma, a rare phenomena.
    Re A; Shersher D; Allen A; Schwarting R; Ren S
    Diagn Cytopathol; 2021 Jun; 49(6):E234-E237. PubMed ID: 33347735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
    Yuan Y; Nymoen DA; Dong HP; Bjørang O; Shih IeM; Low PS; Trope' CG; Davidson B
    Hum Pathol; 2009 Oct; 40(10):1453-60. PubMed ID: 19454358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleuro-pulmonary metastases from a malignant mesothelioma of the tunica vaginalis].
    Pannier D; Caty A; Hysi I; Bouchindhomme B; Copin MC; Porte H; Dansin E
    Rev Mal Respir; 2011 Nov; 28(9):1155-7. PubMed ID: 22123142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.